Business
Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, January 16th During the Veterinary Meeting & Expo (VMX) Conference in Orlando, Florida
Canalevia™-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for CID in dogs to receive any type of
About this update from Jaguar Health, Inc.
[{"type":"text","content":"Canalevia™-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for CID in dogs to receive any type of approval from FDAU.S. veterinarians, veterinary oncologists, and members of the media can click here to register for the CID Treatment Forum; Remote access will be available to participants unable to attend in personSAN FRANCISCO, CA / ACCESSWIRE / January 12, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX), under its Jaguar Animal Health tradename for the veterinary market, today announced that the company is hosting a treatment forum for veterinarians about chemotherapy-induced diarrhea (CID) in dogs on Sunday, January 16 from 6 p.m. - 8 p.m. Eastern during the Veterinary Meeting & Expo (VMX) Conference in Orlando, Florida.Noted veterinary oncologist Dr. Craig A. Clifford, DVM, MS, DACVIM will lead the discussion on the significant burden of disease of chemotherapy-induced diarrhea, share his experience treating dogs with CID, and characterize the clinical profile of Canalevia-CA1, the company's plant-based prescription drug for the treatment of CID in dogs. Remote access to the event will be available to registered veterinarians and members of the media who are unable to attend the CID Treatment Forum in person. Dinner will be provided for attendees participating in person.Participation Details for CID Treatment Forum:Event Date & Time: Sunday, January 16, 2022, from 6 p.m. - 8 p.m. EasternEvent Location: Salon 16 at the Rosen Centre Hotel, which is adjacent to the Orange County Convention Center (the location of VMX)How to Register: U.S. veterinarians, veterinary oncologists, and members of the media can register on the Canalevia.com website for the CID Treatment Forum by clicking hereRemote Access: Live remote access to the event will be available to registered U.S. veterinarians and members of the media who are unable to attend the CID Treatment Forum in personAs part of the launch of Canalevia-CA1, the company is showcasing the product at its exhibit booth at VMX, which takes place January 15-19, 2022, at the Orange County Convention Center in Orlando, FL. Canalevia-CA1 is being commercialized as a prescription drug product under the company's Jaguar Animal Health tradename. Jaguar Animal Health will be exhibiting at VMX booth number 4610.Additional information about VMX, t...